Android app on Google Play

Endo Pharmaceuticals Holdings (ENDP) Reports In-Line Q1 EPS; Reaffirms Outlook

May 1, 2012 7:41 AM EDT Send to a Friend
Get Alerts ENDP Hot Sheet
Trade ENDP Now!
Join SI Premium – FREE
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q1 EPS of $0.87, in-line with the analyst estimate of $0.87. Revenue for the quarter came in at $691 million versus the consensus estimate of $700.34 million.

Endo Pharmaceuticals Holdings reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Endo Pharmaceuticals Holdings (ENDP) click here.




You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment